logo


Syneron to Launch Industry-First Treatment Modality, New Product for Procedures Leading to Body Contouring and Physician-Focused Initiative at THE Aesthetics Show
Wednesday, June 03, 2009 9:01 AM


eMatrix Device Pioneers Sublative Rejuvenation(TM) for Novel Skin Ablation and Resurfacing Leading to Enhanced Dermal Remodeling

VelaShape II(TM) Introduction Provides Reduced Treatment Time, Reduced Number of Treatments and Increased Patient Comfort in Procedures Leading to Body Contouring

Syneron Advantage(TM) Program Increases Attainability and Success of Aesthetic Services Offering

YOKNEAM, ISRAEL and IRVINE, CA -- (Marketwire) -- 06/03/09 -- Syneron Medical Ltd. (NASDAQ: ELOS), http://www.syneron.com, a leading innovator in medical aesthetic devices, will unveil three groundbreaking initiatives at THE Aesthetic Show in Las Vegas, June 5-7. The company will introduce a new and unique treatment modality called Sublative Rejuvenation(TM), which answers the skin rejuvenation market's emerging demand for optimal efficiency, minimal downtime and an affordable procedure price point. In addition, Syneron will release VelaShape II(TM), with increased RF energy for quicker non-invasive procedures leading to body contouring, and launch Syneron Advantage(TM) -- a new physician partnership program to support customers' financial and business needs in today's economic climate.

Recent scientific evaluations using eMatrix(TM), http://www.syneron.com/products/ematrix, led to the identification of Sublative Rejuvenation, a new treatment modality that goes beyond current fractional skin ablation and resurfacing methods. Sublative Rejuvenation utilizes RF sublation, a fractionated bi-polar radio frequency technology in which heat energy is effectively placed into the dermis, producing significant dermal remodeling with the least amount of epidermal disruption. While traditional fractional technologies are most aggressive at the epidermal level, Sublative Rejuvenation delivers energy creating a triangular-shaped pattern of impact where the ablated zone on the skin's surface is narrower. The ablative and particularly coagulative zone widens below the surface, reflecting the higher heating of layers of the dermal connective tissue and collagen. This specific, sublative targeting maximizes clinical results and reduces downtime and risk of adverse reaction. Increased dermal heating leads to stronger collagenesis, making Sublative Rejuvenation most desirable for wrinkle reduction as well as overall textural improvement and luminosity for all skin types.

"Before the introduction of Sublative Rejuvenation with eMatrix, I needed to be extremely careful when performing any kind of ablative or even non-ablative treatment on my patients with darker skin tones because of possible adverse reactions," said Hema Sundaram, M.D., F.A.A.D., a board certified dermatologist in Washington, D.C.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Special Offers
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia